Abstract:Hepatocellular carcinoma (HCC) is the leading cause of cancer-related mortality worldwide due to its asymptomatic onset and poor survival rate. This highlights the urgent need for developing novel diagnostic markers for early HCC detection. The circadian clock is important for maintaining cellular homeostasis and is tightly associated with key tumorigenesis-associated molecular events, suggesting the so-called chronotherapy. An analysis of these core circadian genes may lead to the discovery of biological markers signaling the onset of the disease. In this study, the possible functions of 13 core circadian clock genes (CCGs) in HCC were systematically analyzed with the aim of identifying ideal biomarkers and therapeutic targets. Profiles of HCC patients with clinical and gene expression data were downloaded from The Cancer Genome Atlas and International Cancer Genome Consortium. Various bioinformatics methods were used to investigate the roles of circadian clock genes in HCC tumorigenesis. We found that patients with high TIMELESS expression or low CRY2, PER1, and RORA expressions have poor survival. Besides, a prediction model consisting of these four CCGs, the tumor-node-metastasis (TNM) stage, and sex was constructed, demonstrating higher predictive accuracy than the traditional TNM-based model. In addition, pathway analysis showed that these four CCGs are involved in the cell cycle, PI3K/AKT pathway, and fatty acid metabolism. Furthermore, the network of these four CCGs-related coexpressed genes and immune infiltration was analyzed, which revealed the close association with B cells and nTreg cells. Notably, TIMELESS exhibited contrasting effects against CRY2, PER1, and RORA in most situations. In sum, our works revealed that these circadian clock genes TIMELESS, CRY2, PER1, and RORA can serve as potential diagnostic and prognostic biomarkers, as well as therapeutic targets, for HCC patients, which may promote HCC chronotherapy by rhythmically regulating drug sensitivity and key cellular signaling pathways.

Circadian Telomerase Activity and DNA Synthesis for Timing Peptide Administration

[Circadian Rhythms of DNA Synthesis and Telomerase Expression in Hepatic Cancer Transplanted in Nude Mice].

Chronotherapy by Ribozyme Targeted to Telomerase in Nude Mice with a Transplanted Tumor: Model for Human Hepatic Cancer

Potential cancer-related role of circadian gene TIMELESS suggested by expression profiling and in vitro analyses

Circadian Rhythms of DNA Synthesis and Apoptosis Correlated Gene Expression in Bone Marrow Cells of Nude Mice Bearing Human Nasopharyngeal Carcinoma

The Circadian Rhythm and Core Gene Period2 Regulate the Chemotherapy Effect and Multidrug Resistance of Ovarian Cancer Through the PI3K Signaling Pathway.

Telomerase: A Nexus between Cancer Nano Therapy and Circadian Rhythm

Circadian Timing in Cancer Treatments

Imaging Multidimensional Therapeutically Relevant Circadian Relationships

Dendritic cells direct circadian anti-tumor immune responses

Circadian clock and lipid metabolism disorders: a potential therapeutic strategy for cancer

Time-of-day effects of cancer drugs revealed by high-throughput deep phenotyping

Clocking cancer immunotherapy responses

Dysregulation of Circadian Clock Genes as Significant Clinic Factor in the Tumorigenesis of Hepatocellular Carcinoma

TIMELESS Regulates Sphingolipid Metabolism and Tumor Cell Growth Through Sp1/ACER2/S1P Axis in ER-positive Breast Cancer

Inhibition of Tumorigenesis by Intratumoral Delivery of the Circadian Gene Mper2

Circadian clock associates with tumor microenvironment in thoracic cancers

G1/S cell cycle regulators mediate effects of circadian dysregulation on tumor growth and provide targets for timed anticancer treatment

Chronobiology of the Tumor Microenvironment: Implications for Therapeutic Strategies and Circadian-Based Interventions

Cell-intrinsic, Bmal1-dependent Circadian Regulation of Temozolomide Sensitivity in Glioblastoma